To assess the tumor-initiating cells/cancer stem cell (TIC/CSC) population, we undertook a flow cytometric analysis using standard CSC markers such as CD24 and CD4411, 12 and CD90 [45] (Fig. 6, Supplementary Fig. S7A-C). The gene discussed is THY1; the disease is cancer.